Key result
A Kv4.3/KChIP2.1 bicistronic transgene produced typical Ito,f properties in HEK293 cells and rabbit cardiomyocytes, generating currents similar to human ventricular Ito,f.
Why the study?
Reduction of the fast transient outward potassium current contributes to loss of contractility in heart failure, making its restoration a potential therapeutic strategy.
Population
Transfected HEK293 cells and adenovirus-transduced rabbit cardiomyocytes
Comparison
Kv4.3/KChIP2.1 bicistronic transgene expression
Design
Preclinical in vitro experimental study
Authors
Loading...
Hypothesis-generating for Kv4.3/KChIP2.1 transgene to restore Ito,f; leaves open in vivo efficacy and clinical translation in heart failure.
A Kv4.3/KChIP2.1 bicistronic transgene successfully induces Ito,f current properties in vitro, demonstrating a potential gene therapy approach for restoring repolarization and contractility in heart failure.
Wang et al. (2021) studied Heart failure. Kv4.3/KChIP2.1 bicistronic transgene was evaluated on I to,f properties and current characteristics. A Kv4.3/KChIP2.1 bicistronic transgene produced typical Ito,f properties in HEK293 cells and rabbit cardiomyocytes, generating currents similar to human ventricular Ito,f.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: